- This event has passed.
Sarcoma and Coronavirus Live Expert Chat
April 5, 2020 @ 3:00 pm UTC-4
Sunday, April 5, 2020
3:00 pm EDT
Join the Sarcoma Foundation of America (SFA) and a panel of sarcoma experts to discuss the impact the coronavirus pandemic is having on treatment, clinical trials and other research efforts!
During this difficult time, you may have questions about the coronavirus outbreak and the impact on sarcoma patients, survivors, and caregivers.
SFA is offering a live discussion where you can get your questions answered. The esteemed panel of experts will address your issues and concerns including:
- Accessing treatment and cancer care during the pandemic
- Concerns about coronavirus and being high risk
- Impact on clinical trials and other sarcoma research efforts
Brian A. Van Tine, MD, PhD
Associate Professor of Medicine
Sarcoma Program Director
Barnes and Jewish Hospital
Washington University in St. Louis
Kurt R. Weiss, MD
Associate Professor University of Pittsburgh School of Medicine
Department of Orthopaedic Surgery, Division of Musculoskeletal Oncology
Vice Chair of Translational Research
Director, Musculoskeletal Oncology Laboratory
University of Pittsburgh School of Medicine
Breelyn A. Wilky, MD
Associate Professor, Director of Sarcoma Translational Research
Department of Medicine, Division of Medical Oncology
Deputy Associate Director for Clinical Research, University of Colorado Cancer Center
University of Colorado Anschutz Medical Campus
SFA will collect questions in advance and through the chat during the discussion on Sunday, April 5 and the panelists will answer the questions live.
To join the discussion, register below and submit any questions you may have in advance. You can also submit questions through the chat feature during the event and anytime on social media using the hashtag #SFAScienceSunday. Instructions on how to access the live discussion will be emailed to you!
This session is free and open to everyone so please share with anyone you know who might be interested in joining the discussion.
Questions? Email us at firstname.lastname@example.org.